Acute generalized exanthematous pustulosis following oral nystatin therapy: A report of three cases

British Journal of Dermatology

Volumn 137, Issue 5, 1997, Pages 808-811

  Kuchler A ^a   Hamm, H ^a   Weidenthaler Barth, B ^a   Kampgen E ^a   Brocker E B ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOFANAL; CLEMASTINE; GENTAMICIN; METHYLPREDNISOLONE; NYSTADERM; NYSTATIN; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DELAYED HYPERSENSITIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATCH TEST; PRICK TEST; PRIORITY JOURNAL; PUSTULOSIS; RASH; TOPICAL DRUG ADMINISTRATION;

EID: 0030667877     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01124.x     Document Type: Article

References (24)

1. Roujeau J-C, Bioulac-Sage P, Bourseau C et al. Acute generalized exanthematous pustulosis. Arch Dermatol 1991; 127: 1333-8.
2. Wasilewski C. Allergic contact dermatitis from nystatin. Arch Dermatol 1970; 102: 216-17.
3. Coskey RJ. Contact dermatitis due to nystatin. Arch Dermatol 1971; 103: 228.
4. Lang E, Goos M. Combined allergy to tolnaftate and nystatin. Contact Dermatitis 1985; 12: 182.
5. Kandil E. Fixed drug eruption. Dermatologist 1969; 139: 37-40.
6. Pareek SS. Nystatin-induced fixed eruption. Br J Dermatol 1980; 103: 679-80.
7. Garty B-Z. Stevens-Johnson syndrome associated with nystatin treatment. Arch Dermatol 1991; 127: 741-2.
8. von Zumbusch R, Museler A, Schön B. Systemische Reaktion auf Nystatin. Allergologie 1994; 17: 271-2.
9. Petrozzi JW, Witkowski JA. Acrodermatitis perstans. Generalization following therapy with nystatin. Arch Dermatol 1971; 103: 442-7.
10. Stevanovic DV. Erythemo-squamous and pustular spongiform eruption. Dermatologica 1969; 138: 379-90.
11. Staughton RCD, Rowland Payne CME, Harper JI, McMichen H. Toxic pustuloderma - a new entity? J R Soc Med 1984; 77 (Suppl.4): 6-8.
12. Rustin MHA, Robinson TWE, Dowd PM. Toxic pustuloderma: a self-limiting eruption. Br J Dermatol 1990; 123: 119-24.
13. Beylot C, Bioulac P, Doutre MS. Pustuloses exanthématiques aigues généralisées. A propos de 4 cas. Ann Dermatol Venereol (Paris) 1980; 107: 37-48.
14. Baker H, Ryan TJ. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol 1968; 80: 771-93.
15. Spencer JM, Silvers DN, Grossman ME. Pustular eruption after drug exposure: is it pustular psoriasis or a pustular drug eruption? Br J Dermatol 1994; 130: 514-19.
16. Burrows NP, Russell Jones R. Pustular drug eruptions: a histopathological spectrum. Histopathology 1993; 22: 569-73.
17. Auer-Grumbach P, Pfaffenthaler E, Soyer HP. Pustulosis acuta generalisata is a post-streptococcal disease and is distinct from acute generalized exanthematous pustulosis. Br J Dermatol 1995; 133: 135-9.
18. Wakelin SH, James MP. Diltiazem-induced acute generalized exanthematous pustulosis. Clin Exp Dermatol 1995; 20: 341-4.
19. Gebhardt M, Lustig A, Bocker T, Wollina V. Acute generalized exanthematous pustulosis (AGEP): manifestation of drug allergy to propicillin. Contact Dermatitis 1995; 33: 204-5.
20. Moreau A, Dompmartin A. Drug-induced acute generalized exanthematous pustulosis with positive patch tests. Int J Dermatol 1995; 43: 263-6.
21. Trüeb RM, Burg G. Acute generalized exanthematous pustulosis due to doxycycline. Dermatology 1993; 186: 75-8.
22. Tsuda S, Kato K, Karashima T et al. Toxic pustuloderma induced by ofloxacin. Acta Derm Venereol (Stockh) 1993; 73: 382-4.
23. Ogoshi M, Yamada Y, Tani M. Acute generalized exanthematic pustulosis induced by cefaclor and acetazolamide. Dermatology 1992; 184: 142-4.
24. Feind-Koopmans A, van der Valk PGM, Steijlen PM, van de Kerkhof PCM. Toxic pustuloderma associated with demastine therapy. Clin Exp Dermatol 1996; 21: 293-5.